Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 162 results for atrial fibrillation

  1. Pulsed Field Ablation (PFA) for atrial fibrillation

    Awaiting development [GID-IPG10267] Expected publication date: 12 June 2025

    Interventional procedures guidance
    Awaiting development

  2. Insights from the NHS: the adoption of self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for atrial fibrillation and heart valve disease

    self‑monitoring coagulation status using point‑of‑care coagulometers for atrial fibrillation and heart valve disease. Guidance

    Shared learning
    Last updated
    5 July 2016

  3. Cardiometabolic disease prevention and treatment guidelines

    failure: diagnosis and management - To be confirmed Atrial fibrillation: diagnosis and management - To be confirmed Cardiovascular

    NICE guideline
    In development

  4. AcQMap for mapping the heart atria to target ablation treatment for arrhythmias (MIB246)

    NICE has developed a medtech innovation briefing (MIB) on AcQMap for mapping the heart atria to target ablation treatment for arrhythmias .

    Medtech innovation briefing
    Published
    26 January 2021

  5. Reducing the risk of stroke in AF: using the NICE PDA with patients not currently treated with anticoagulants

    identified patients in each practice with AF who were not treated according to the NICE guidance for Atrial fibrillation...

    Shared learning
    Last updated
    5 July 2021

  6. The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the preceding 2 years.

    percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA,...

    General practice indicator suitable for use in the QOF
    Published
    27 April 2021

  7. Percentage of patients with atrial fibrillation and a last recorded CHA2DS2-VASc score of 2 or more who are currently prescribed a direct-acting oral anticoagulant (DOAC) if eligible, or a vitamin K antagonist if not eligible for a DOAC or a DOAC is declined or not indicated

    Percentage of patients with atrial fibrillation and a last recorded CHA2DS2-VASc score of 2 or more who are currently prescribed a...

    General practice indicator suitable for use in the QOF
    Published
    30 November 2022

  8. Thyroid disease: assessment and management (NG145)

    This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.

    NICE guideline
    Last updated
    12 October 2023
    View recommendations

    Sections for NG145

  9. Zio XT for detecting cardiac arrhythmias (MTG52)

    Evidence-based recommendations on Zio XT for detecting cardiac arrhythmias.

    Medical technologies guidance
    Published
    1 December 2020
    View recommendations

    Sections for MTG52

  10. Stopping anticoagulation after resolution of postoperative atrial fibrillation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose postoperative atrial fibrillation after cardiac surgery has resolved?

    postoperative atrial fibrillation: What is the clinical and cost effectiveness of stopping anticoagulation in people whose postoperative...

    Research recommendation
    Published
    10 August 2021

  11. Cognitive behavioural therapy for people with atrial fibrillation: What is the clinical and cost effectiveness of cognitive behavioural therapy compared with usual care for people with newly diagnosed atrial fibrillation?

    Question Cognitive behavioural therapy for people with atrial fibrillation: What is the clinical and cost effectiveness of cognitive...

    Research recommendation
    Published
    10 August 2021

  12. The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which included: assessment of stroke/VTE risk; assessment of bleeding risk; assessment of renal function, creatinine clearance, FBC and LFTs as appropriate for their anticoagulation therapy; any adverse effects related to anticoagulation; assessment of compliance; choice of anticoagulant

    The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12...

    General practice indicator suitable for use in the QOF
    Published
    27 April 2021

  13. KODEX-EPD for cardiac imaging during ablation of arrhythmias (MIB260)

    NICE has developed a medtech innovation briefing (MIB) on KODEX-EPD for cardiac imaging during ablation of arrhythmias .

    Medtech innovation briefing
    Published
    11 May 2021

  14. The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:- What is the optimal NT-proBNP threshold for the diagnosis of heart failure in people with atrial fibrillation?

    Recommendation ID NG106/3 Question The impact of atrial fibrillation on the natriuretic peptide threshold for diagnosing heart failure:-...

    Research recommendation
    Published
    17 December 2018

  15. Automated blood pressure monitoring in people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial fibrillation?

    people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial...

    Research recommendation
    Published
    11 April 2022